| Dr. Friedlander received
              his undergraduate education at Bowdoin College in Brunswick, Maine
              where he
              graduated with Highest Honors in Biology. He completed his Ph.D. at the
              University of Chicago in the Committee on Developmental Biology and
              his
              M.D. at the State University of New York, Downstate Medical Center. He
              journeyed to the west coast for his clinical training in ophthalmology,
              completing a residency and retina fellowship at the Jules Stein Eye
              Institute
              at the University of California, Los Angeles. He has been on the faculties
              of the Rockefeller University (where he worked with Professor Gunter
              Blobel,
              the 1999 Nobel Laureate in Physiology and Medicine) and the University
              of California, Los Angeles prior to joining the staff of the Scripps
              Research
              Institute and Scripps Memorial Hospital in 1993. He is presently a 
              Professor in the Department of Cell Biology and the Graduate Program
              in Macromolecular and Cellular Structure and Chemistry at The Scripps
              Research
              Institute. He is a Staff Ophthalmologist and Chief of the Retina Service
              at Scripps Clinic and Green Hospital as well as a Staff Ophthalmologist
              at Scripps Memorial Hospital. Dr. Friedlander has been a scholar of
              the
              Sinsheimer Foundation and the Heed Ophthalmic Foundation and his research
              is supported by the National Institutes of Health (National Eye Institute)
              and The Robert Mealey Program for the Study of Macular Degenerations.
              His research interests focus on understanding basic underlying mechanisms
              of ocular angiogenesis and identifying therapeutic approaches to treating
              ocular neovascular diseases such as macular degeneration and diabetic
              retinopathy. He has also had a long-standing interest in targeting,
              translocation
              and integration of polytopic membrane proteins including rhodopsin and
              sodium-calcium exchangers. The two research programs are integrated by 
              their application to the treatment of neovascular eye disease and inherited 
              retinal degenerations.     |